Peptide Knowledge Base · Metabolic

AOD-9604: what it is, what the evidence says, and its real status

A GH-fragment pitched for fat loss whose human trials largely disappointed.

Can you actually get it?

Plain-English verdict: No availability record.

Regulatory status: No regulatory record.

How does AOD-9604 work?

A synthetic fragment of the C-terminus of human growth hormone, proposed to influence fat metabolism without GH's systemic effects.

What it does — and what it does not do

What it does: Studied for fat metabolism.

What it does not do: It did not show meaningful weight loss in controlled human trials, and it is not offered here.

How honest is the evidence?

Evidence grade D — Animal and lab evidence; human trials still to come.

controlled human fat-loss trials largely negative

A grade measures how much human evidence exists, not whether a molecule is good, safe, or worth your interest. Read our grading methodology for what each grade means.

What we still don't know: No credible evidence of clinically meaningful fat loss in humans.

WADA status: Not prohibited.

Who should not take it

Not characterized for any therapeutic use; not a weight-loss treatment.

Sources

AOD-9604 clinical trial literature (predominantly negative for weight loss)

Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker for status.

Join the founding list →

Embed this card on your site · free, CC BY 4.0, no key.

Last reviewed Jun 16, 2026 · Peptós.LIFE · Not medical advice.